New Nerve Stimulation Shows Promise for Sleep Apnea – Alternative to CPAP

Nearly one billion people worldwide suffer from obstructive sleep apnea (OSA), a chronic respiratory disorder that significantly diminishes quality of life and increases the risk of cardiovascular, metabolic, and neurocognitive issues. Despite the availability of continuous positive airway pressure (CPAP) therapy – currently the standard treatment – almost half of patients struggle to tolerate it. Researchers at Flinders University in Australia have been exploring an alternative approach: stimulating the hypoglossal nerve, which controls the muscles of the tongue.

A Targeted Therapy for an Underestimated Respiratory Issue

Obstructive sleep apnea is a widespread, yet often undiagnosed, condition that disrupts breathing during sleep. It manifests as repeated pauses in breathing caused by the relaxation of throat muscles, leading to a temporary collapse of the upper airways. These interruptions reduce blood oxygen levels, fragment sleep, and contribute to metabolic, cognitive, and cardiovascular problems. According to the study, over 80% of moderate to severe cases of OSA remain untreated or poorly managed.

CPAP therapy works by maintaining constant air pressure to keep the airways open. While effective, many users discontinue treatment within six months due to discomfort from the mask, air leaks, noise, or a sensation of suffocation. This lack of adherence leaves many patients vulnerable to the risks of untreated apnea.

To address this challenge, research is focusing on alternatives that directly target the underlying cause of the disorder. Hypoglossal nerve stimulation (HNS) is one such solution. The hypoglossal nerve controls the tongue muscles, which often have insufficient tone during sleep. By stimulating this nerve, researchers aim to prevent airway collapse.

While HNS technology isn’t new, existing implantable devices require extensive surgery. The study led by Amal M. Osman and her team introduces a significant advancement: a simpler, more accessible, and faster stimulation method that avoids surgical implantation while still targeting the same crucial neuromuscular mechanism.

An Innovative Nerve Stimulation Protocol Tested Under Controlled Conditions

The study was conducted in a rigorous experimental setting to evaluate a non-surgical hypoglossal nerve stimulation method. The Flinders University team selected fourteen participants with moderate to severe obstructive sleep apnea.

The procedure involved inserting a network of linear electrodes under the skin around the hypoglossal nerve, guided by ultrasound. Traditional implants require a surgical incision and a permanent housing unit. This percutaneous method, however, takes approximately 90 minutes to complete without general anesthesia. The electrodes were connected to an external generator allowing real-time modulation of stimulation parameters.

Participants were placed in a simulated sleep state using light sedation, replicating the physiological conditions of apnea. Researchers then assessed two key indicators: maximum inspiratory flow and critical airway pressure (Pcrit). Inspiratory flow reflects the air’s ability to pass despite obstruction, while Pcrit indicates the propensity for airway collapse.

Thirteen of the fourteen patients showed a positive response to the stimulation. In these individuals, inspiratory flow improved significantly, reaching levels comparable to those observed with CPAP therapy. Pcrit also decreased substantially, indicating a more stable maintenance of airway openness.

Tolerance, Simplicity, and Speed: Marked Clinical Advantages

Beyond its respiratory effectiveness, the tested method offers concrete clinical advantages. Unlike conventional implantable systems, this approach doesn’t involve invasive surgery, scarring, or permanent subcutaneous devices. The percutaneous electrode placement reduces surgical risks, lowers medical costs, and significantly shortens the procedure’s duration.

Ultrasound guidance ensures optimal precision during insertion, minimizing neurological or muscular complications. According to Simon Carney, an oto-rhino-laryngologist involved in the study, in a statement, “this protocol is designed to be applied in the clinic with a minimum of logistical constraints, while maintaining efficacy equivalent to traditional approaches.” He notes the procedure could be widely adopted in an outpatient setting, enhancing accessibility.

The external stimulation system also allows for fine-tuning of impulses without requiring surgical reprogramming, offering significant individual adaptability based on patient response. Unlike CPAP, which imposes continuous nightly constraints, hypoglossal stimulation doesn’t interfere with sleep comfort or rhythm.

No major complications were reported among participants. Minor side effects, such as transient tingling, resolved without treatment. The procedure was deemed highly acceptable, and most participants expressed a willingness to continue using the method if it became available.

A Credible Alternative for Patients at a Therapeutic Impasse

The potential of this method is also viewed in light of the limitations of existing solutions. CPAP rejection has significant consequences, increasing the risk of cardiovascular accidents, resistant hypertension, and severe daytime sleepiness, with substantial socio-economic impacts.

Implantable hypoglossal stimulation devices, already approved in several countries, are limited by their high cost, restricted availability, and the need for specialized surgery, excluding many patients, particularly those in healthcare systems with limited resources or those with surgical contraindications.

This study opens the door to a more flexible therapeutic model. The ability to apply stimulation temporarily allows for reversible testing, personalized responses, and a progressive adoption approach tailored to patient preferences.

From a scientific perspective, this method could also integrate into hybrid protocols, complementing positional therapy or weight loss to enhance effects without imposing a single solution. It could also identify, through acute testing, those patients most likely to benefit from a permanent implant.

The authors emphasize the need for further research. Larger-scale trials, under natural sleep conditions and over multiple nights, are necessary to confirm the durability of the observed effects. However, these initial results offer a concrete glimpse of a credible alternative, tailored to the real-world challenges encountered in clinical practise.

Source: Osman, Amal M. Et al., “Effect of Novel Hypoglossal Stimulation on Airflow and Airway Collapsibility in OSA”. CHEST, Volume 169, Issue 1, 257 – 268, 2026

Frequently Asked Questions

What is obstructive sleep apnea?

Obstructive sleep apnea is a common, often undiagnosed, condition that disrupts breathing during sleep due to repeated pauses caused by the relaxation of throat muscles and a temporary collapse of the upper airways.

What is the current standard treatment for OSA?

The current standard treatment for obstructive sleep apnea is continuous positive airway pressure (CPAP) therapy, which maintains constant air pressure to keep the airways open.

How does this new method differ from existing HNS treatments?

This new method avoids surgical implantation of devices, utilizing a percutaneous approach to insert electrodes around the hypoglossal nerve, making it simpler, faster, and more accessible than traditional implantable systems.